National Cancer Centre Singapore - Academic Profile

Publications

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Frances A. Shepherd , José Rodrigues Pereira , Tudor‐Eliade Ciuleanu +16 more

Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.

2005 New England Journal of Medicine 5425 citations

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Nick Thatcher , Alex Y. Chang , Purvish M. Parikh +8 more

2005 The Lancet 2086 citations

The landscape of cancer genes and mutational processes in breast cancer

Philip J. Stephens , Patrick Tarpey , Helen Davies +59 more

All cancers carry somatic mutations in their genomes. A subset, known as driver mutations, confer clonal selective advantage on cancer cells and are causally implicated in oncog...

2012 Nature 1700 citations

Affiliated Researchers

Institution Info

Type: healthcare
Country: SG
Publications: 3
Citations: 9,211

External Links

Identifiers

ROR: https://ror.org/03bqk3e80